We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+23.97%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.1B
AUM Growth
+$336M
Cap. Flow
-$54.6M
Cap. Flow %
-2.6%
Top 10 Hldgs %
22.32%
Holding
3,256
New
220
Increased
669
Reduced
421
Closed
197

Sector Composition

Rank Sector Weight
1 Technology 17.63%
2 Financials 10.35%
3 Healthcare 10.15%
4 Consumer Discretionary 9.52%
5 Industrials 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZNTL icon
1901
Zentalis Pharmaceuticals
ZNTL
$257M
$44K ﹤0.01%
+913
New +$35K
CKH
1902
DELISTED
Seacor Holdings Inc.
CKH
$44K ﹤0.01%
1,557
APLT
1903
DELISTED
Applied Therapeutics
APLT
$43K ﹤0.01%
1,179
+630
+115% +$26.4K
CTBI icon
1904
Community Trust Bancorp
CTBI
$1.44B
$43K ﹤0.01%
1,316
CVM icon
1905
CEL-SCI Corp
CVM
$26.9M
$43K ﹤0.01%
96
+18
+23% +$7.39K
ENVA icon
1906
Enova International
ENVA
$6.59B
$43K ﹤0.01%
2,903
FCEL icon
1907
FuelCell Energy
FCEL
$1.82B
$43K ﹤0.01%
+627
New +$38.6K
HLX icon
1908
Helix Energy Solutions
HLX
$1.55B
$43K ﹤0.01%
12,468
KNSA icon
1909
Kiniksa Pharmaceuticals
KNSA
$5.96B
$43K ﹤0.01%
1,680
+705
+72% +$14.7K
PAHC icon
1910
Phibro Animal Health
PAHC
$1.4B
$43K ﹤0.01%
1,619
PAR icon
1911
PAR Technology
PAR
$776M
$43K ﹤0.01%
1,420
+547
+63% +$12K
QNST icon
1912
QuinStreet
QNST
$1.19B
$43K ﹤0.01%
4,141
TBBK icon
1913
The Bancorp
TBBK
$2.84B
$43K ﹤0.01%
4,384
URGN icon
1914
UroGen Pharma
URGN
$2.33B
$43K ﹤0.01%
1,653
CIR
1915
DELISTED
CIRCOR International, Inc
CIR
$43K ﹤0.01%
1,669
CLVS
1916
DELISTED
Clovis Oncology, Inc.
CLVS
$43K ﹤0.01%
6,387
+2,420
+61% +$18.3K
ABTX
1917
DELISTED
Allegiance Bancshares
ABTX
$43K ﹤0.01%
1,683
BANC icon
1918
Banc of California
BANC
$3.11B
$42K ﹤0.01%
3,886
BSCP
1919
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$42K ﹤0.01%
1,934
+4
+0.2% +$87
CPRX
1920
DELISTED
Catalyst Pharmaceutical
CPRX
$42K ﹤0.01%
9,063
CRBP icon
1921
Corbus Pharmaceuticals
CRBP
$198M
$42K ﹤0.01%
167
CRNX icon
1922
Crinetics Pharmaceuticals
CRNX
$8.98B
$42K ﹤0.01%
2,390
+1,438
+151% +$24.5K
FLWS icon
1923
1-800-Flowers.com
FLWS
$261M
$42K ﹤0.01%
2,081
KELYA icon
1924
Kelly Services Class A
KELYA
$555M
$42K ﹤0.01%
2,680
NFBK
1925
DELISTED
Northfield Bancorp
NFBK
$42K ﹤0.01%
3,620

Similar funds

Ameritas Investment Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Ameritas Investment Partners held 3,256 positions worth $2.1B, up 19% from $1.76B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Ameritas Investment Partners's Q2 2020 filing shows 220 new, 669 increased, 421 reduced and 197 closed positions. Its largest new stake was Otis Worldwide: 26,459 shares worth $1.5M. The largest sale was Vanguard S&P 500 ETF, an estimated $5.92M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Ameritas Investment Partners's largest Q2 2020 buy was Otis Worldwide: 26,459 shares worth $1.5M.
  • Ameritas Investment Partners added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q2 2020, an estimated $8.49M increase.
  • Ameritas Investment Partners's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $5.92M.
  • Ameritas Investment Partners fully exited Cypress Semiconductor in Q2 2020, selling an estimated $2.42M.
  • Ameritas Investment Partners's ten largest holdings make up 22% of its $2.1B portfolio in Q2 2020.
  • Ameritas Investment Partners opened 220 new positions and closed 197 in Q2 2020.
  • Ameritas Investment Partners's portfolio value rose 19% quarter-over-quarter to $2.1B.

Based on Ameritas Investment Partners's 13F filing for Q2 2020, filed 5 Aug 2020.